Skip to content
10-Q

Quarterly Report

Natus Medical Inc

0000878526-21-000110

← back to feed
Filed
Nov 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 29, 2021 34.15M sh
Shares Diluted Q3 2021 · Sep 30, 2021 33.87M sh
Shares Diluted Q3 2021 · Sep 30, 2021 33.88M sh
Shares Diluted Q3 2021 · Sep 30, 2020 33.83M sh
Shares Diluted Q3 2021 · Sep 30, 2020 33.58M sh
Stock Repurchased Q3 2021 · Sep 30, 2021 $0
Stock Repurchased Q3 2021 · Sep 30, 2020 $10.5M
Capex Q3 2021 · Sep 30, 2021 $2.95M
Capex Q3 2021 · Sep 30, 2020 $7.62M
Operating Cash Flow Q3 2021 · Sep 30, 2021 $51.21M
Operating Cash Flow Q3 2021 · Sep 30, 2020 $17.1M
Long Term Debt Q3 2021 · Sep 30, 2021 $0
Long Term Debt Q3 2021 · Dec 31, 2020 $5.84M
Short Term Debt Q3 2021 · Sep 30, 2021 $0
Short Term Debt Q3 2021 · Dec 31, 2020 $50M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $68.78M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $82.08M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $74.54M
Cash And Equivalents Q3 2021 · Dec 31, 2019 $63.3M
Stockholders Equity Q3 2021 · Sep 30, 2021 $422.52M
Stockholders Equity Q3 2021 · Jun 30, 2021 $417.83M
Stockholders Equity Q3 2021 · Mar 31, 2021 $408.93M
Stockholders Equity Q3 2021 · Dec 31, 2020 $411.09M
Stockholders Equity Q3 2021 · Sep 30, 2020 $395.47M
Stockholders Equity Q3 2021 · Jun 30, 2020 $395.47M
Stockholders Equity Q3 2021 · Mar 31, 2020 $398.15M
Stockholders Equity Q3 2021 · Dec 31, 2019 $416.12M
Current Liabilities Q3 2021 · Sep 30, 2021 $103.8M
Current Liabilities Q3 2021 · Dec 31, 2020 $145.75M
Total Liabilities Q3 2021 · Sep 30, 2021 $138.73M
Total Liabilities Q3 2021 · Dec 31, 2020 $189.3M
Current Assets Q3 2021 · Sep 30, 2021 $261.67M
Current Assets Q3 2021 · Dec 31, 2020 $271.7M
Total Assets Q3 2021 · Sep 30, 2021 $561.25M
Total Assets Q3 2021 · Dec 31, 2020 $600.39M
Eps Diluted Q3 2021 · Sep 30, 2021 $0.16
Eps Diluted Q3 2021 · Sep 30, 2021 $0.34
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.28
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.65
Eps Basic Q3 2021 · Sep 30, 2021 $0.17
Eps Basic Q3 2021 · Sep 30, 2021 $0.34
Eps Basic Q3 2021 · Sep 30, 2020 −$0.28
Eps Basic Q3 2021 · Sep 30, 2020 −$0.65
Sga Expense Q3 2021 · Sep 30, 2021 $12.85M
Sga Expense Q3 2021 · Sep 30, 2021 $40.32M
Sga Expense Q3 2021 · Sep 30, 2020 $12.38M
Sga Expense Q3 2021 · Sep 30, 2020 $36.75M
Rd Expense Q3 2021 · Sep 30, 2021 $14.27M
Rd Expense Q3 2021 · Sep 30, 2021 $42.56M
Rd Expense Q3 2021 · Sep 30, 2020 $14.67M
Rd Expense Q3 2021 · Sep 30, 2020 $46.57M
Net Income Q3 2021 · Sep 30, 2021 $5.57M
Net Income Q3 2021 · Sep 30, 2021 $11.43M
Net Income Q3 2021 · Jun 30, 2021 $3.46M
Net Income Q3 2021 · Mar 31, 2021 $2.4M
Net Income Q3 2021 · Sep 30, 2020 −$9.32M
Net Income Q3 2021 · Sep 30, 2020 −$21.82M
Net Income Q3 2021 · Jun 30, 2020 −$8.9M
Net Income Q3 2021 · Mar 31, 2020 −$3.6M
Operating Income Q3 2021 · Sep 30, 2021 $8.55M
Operating Income Q3 2021 · Sep 30, 2021 $19.08M
Operating Income Q3 2021 · Sep 30, 2020 −$9.94M
Operating Income Q3 2021 · Sep 30, 2020 −$25.21M
Gross Profit Q3 2021 · Sep 30, 2021 $67.75M
Gross Profit Q3 2021 · Sep 30, 2021 $200.64M
Gross Profit Q3 2021 · Sep 30, 2020 $47.53M
Gross Profit Q3 2021 · Sep 30, 2020 $150.86M
Revenue Q3 2021 · Sep 30, 2021 $113.88M
Revenue Q3 2021 · Sep 30, 2021 $344.78M
Revenue Q3 2021 · Sep 30, 2020 $102.8M
Revenue Q3 2021 · Sep 30, 2020 $296.97M